Microarray analysis of differentially-expressed genes and linker genes associated with the molecular mechanism of colorectal cancer.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 27899990)

Published in Oncol Lett on September 12, 2016

Authors

Xingjie Shen1, Meng Yue1, Fansheng Meng2, Jingyu Zhu1, Xiaoyan Zhu1, Yakun Jiang1

Author Affiliations

1: Department of Gastroenterology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China.
2: Department of Pharmacy, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China.

Articles citing this

Analysis of long non-coding RNA expression profiles in ovarian cancer. Oncol Lett (2017) 0.75

Articles cited by this

Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52

KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00

DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79

The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08

Human Protein Reference Database--2009 update. Nucleic Acids Res (2008) 21.25

Reactome: a knowledgebase of biological pathways. Nucleic Acids Res (2005) 20.05

Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res (2008) 15.69

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Nature (2010) 15.63

Molecular mechanisms and clinical applications of angiogenesis. Nature (2011) 13.36

PID: the Pathway Interaction Database. Nucleic Acids Res (2008) 12.92

Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86

Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer (2013) 6.13

Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell (2008) 5.88

Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell (2010) 5.47

Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology (2008) 5.19

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J (2010) 3.68

Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol (2009) 3.55

Prostaglandins and cancer. Gut (2005) 3.44

Cytoscape: software for visualization and analysis of biological networks. Methods Mol Biol (2011) 2.43

The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes. Mol Cancer Res (2002) 2.01

The metabolic serine hydrolases and their functions in mammalian physiology and disease. Chem Rev (2011) 1.89

Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie (2005) 1.76

Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions. Biochim Biophys Acta (2009) 1.46

An update on the genetics of colorectal cancer. Hum Mol Genet (2004) 1.39

Tgf-beta signaling alterations and colon cancer. Cancer Treat Res (2010) 1.37

Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines. Proc Natl Acad Sci U S A (2011) 1.30

Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol (2008) 1.30

The role of cyclooxygenase-2 and prostaglandins in colon cancer. Prostaglandins Other Lipid Mediat (2006) 1.29

Colorectal dysplasia in chronic inflammatory bowel disease: pathology, clinical implications, and pathogenesis. Arch Pathol Lab Med (2010) 1.20

Relationship between genetic alterations and prognosis in sporadic colorectal cancer. Int J Cancer (2006) 1.16

Reproducibility Probability Score--incorporating measurement variability across laboratories for gene selection. Nat Biotechnol (2006) 1.12

The Benjamini-Hochberg method in the case of discrete test statistics. Int J Biostat (2007) 1.11

Retinaldehyde dehydrogenase 1 coordinates hepatic gluconeogenesis and lipid metabolism. Endocrinology (2012) 1.05

Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer. Mol Cancer (2014) 1.00

Visualizing gene-set enrichment results using the Cytoscape plug-in enrichment map. Methods Mol Biol (2011) 0.98

Udp-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancer. Int J Cancer (2010) 0.95

Focus on molecules: ALDH1A1: from lens and corneal crystallin to stem cell marker. Exp Eye Res (2011) 0.94

Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer. BMC Cancer (2009) 0.91

Mechanism of fluorescent fatty acid transfer from adipocyte fatty acid binding protein to membranes. Biochemistry (1993) 0.90

Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers. Metabolism (2009) 0.86

Molecular control of the hyaluronan biosynthesis. Connect Tissue Res (2008) 0.86

Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer. Int J Cancer (2013) 0.84